Statistical analyses showed that the expression of IRF4 in the MM stage III patients were significantly higher in patients with disease stages I & II (D-S stage: p = 0.024, Figure 1D; ISS stage: p = 0.002, Figure 1E). Here, IRF4 is linked to Miyoshi myopathy.